A number of neuroprotective compounds that have been studied in PD animal models also affect caspases, such as telmisartan (an angiotensin II type 1 receptor blocker) (Tong et al., 2016), and nerve growth factor (NGF) (Shimoke & Chiba, 2001). Here, AGTR1 is linked to Parkinson disease.